These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes? Sathyapalan T; Atkin SL Minerva Endocrinol; 2011 Jun; 36(2):147-56. PubMed ID: 21519323 [TBL] [Abstract][Full Text] [Related]
26. Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options. Potenza MA; Nacci C; De Salvia MA; Sgarra L; Collino M; Montagnani M Pharmacol Res; 2017 Jun; 120():226-241. PubMed ID: 28408314 [TBL] [Abstract][Full Text] [Related]
27. [Inflammation and atherothrombosis. Premature vascular injury. Diagnostic and therapeutic options for primary prevention]. Ortiz Arduán A; Ruiz Ortega M; Cases Amenós A Nefrologia; 2008; 28 Suppl 3():23-7. PubMed ID: 19018734 [TBL] [Abstract][Full Text] [Related]
28. Psychoneuroimmune implications of type 2 diabetes. O'Connor JC; Johnson DR; Freund GG Neurol Clin; 2006 Aug; 24(3):539-59. PubMed ID: 16877123 [TBL] [Abstract][Full Text] [Related]
29. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Hummasti S; Hotamisligil GS Circ Res; 2010 Sep; 107(5):579-91. PubMed ID: 20814028 [TBL] [Abstract][Full Text] [Related]
30. Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit? Maiorino MI; Bellastella G; Giugliano D; Esposito K Endocrine; 2017 Feb; 55(2):360-365. PubMed ID: 27230767 [TBL] [Abstract][Full Text] [Related]
31. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Rizvi M; Pathak D; Freedman JE; Chakrabarti S Trends Mol Med; 2008 Dec; 14(12):530-8. PubMed ID: 18977174 [TBL] [Abstract][Full Text] [Related]
32. Atherosclerosis associated with dynamic inflammation changes after multifactorial intervention in short-duration type 2 diabetes: A randomized, controlled, 10-year follow-up trial. Shi C; Men L; Yu C; Yao J; Bai R; Yang Y; Sun L; Sun G; Song G; Zhang Y; Xing Q; Du J J Diabetes Complications; 2017 Aug; 31(8):1286-1292. PubMed ID: 28610945 [TBL] [Abstract][Full Text] [Related]
33. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
34. Use of insulin to improve glycemic control in diabetes mellitus. Dandona P; Chaudhuri A; Ghanim H; Mohanty P Cardiovasc Drugs Ther; 2008 Jun; 22(3):241-51. PubMed ID: 18347965 [TBL] [Abstract][Full Text] [Related]
35. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
37. [Obesity, inflammation and diabetes]. Miranda-Garduño LM; Reza-Albarrán A Gac Med Mex; 2008; 144(1):39-46. PubMed ID: 18619057 [TBL] [Abstract][Full Text] [Related]
38. Atherosclerosis revisited from a clinical perspective: still an inflammatory disease? Santovito D; Weber C Thromb Haemost; 2017 Jan; 117(2):231-237. PubMed ID: 27975102 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach. Jurcuţ C; Jurcuţ R; Tănăsescu C Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138 [TBL] [Abstract][Full Text] [Related]
40. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. Garbossa SG; Folli F Rev Endocr Metab Disord; 2017 Jun; 18(2):243-258. PubMed ID: 28409320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]